welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
active, not recruiting

Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy

key information

study id #: NCT01648634

condition: Duchenne Muscular Dystrophy, Cardiomyopathy, Heart Failure

status: active, not recruiting


The objective is to determine whether nebivolol, a beta-blockade drug, can prevent the development of heart disease in patients with Duchenne muscular dystrophy aged 10 to 15 year-old.

intervention: Nebivolol, Placebo

mechanism of action: Beta-blocker to prevent cardiac function deterioration

results: https://clinicaltrials.gov/ct2/show/results/NCT01648634

last updated: November 22, 2018